Conformal Stock
HealthTechLooking to sell Conformal stock or options?
Conformal has developed a medical implant device aimed at preventing strokes in patients with atrial fibrillation. This innovative device is specifically designed for non-valvular atrial fibrillation and adapts to the unique anatomy of each patient, ensuring effective atrial appendage closure. By providing this tailored solution, Conformal enables doctors and medical professionals to effectively treat patients at risk of strokes, ultimately saving lives.
Investors Include:
The Ropart Asset Management Funds, Excelestar Ventures, Catalyst Health Ventures, Sprig Equity, Fidelity Management & Research, Angel Physicians Fund.